MicroRNAs and exosomes: promising new biomarkers in acute myeloid leukemias?
Einstein (Säo Paulo)
;
20: eRB5954, 2022. tab
Artículo
en Inglés
| LILACS
| ID: biblio-1364790
ABSTRACT
ABSTRACT Despite advances in understanding of carcinogenesis and of treatment of acute myeloid leukemia, this neoplasm still has a lethality of at least 30%. The search for biomarkers that can predict the response to treatment in the early stages of the disease is still necessary. In recent years, a new form of cellular communication between tumor and non-neoplastic cells has been discovered the exchange of information through extracellular vesicles. These are small vesicles released by membrane-coated cells that carry proteins, lipids, messenger RNAs, microRNA and DNA, which can be internalized and promote biological changes in target cells. Exosomes are qualified as a type of extracellular vesicle and, in tumors, carry immunoinhibitory signals that promote the escape of immune control. Recent studies have showed their involvement in communication with the cells of the tumor microenvironment and with chemoresistance in several tumors. To date, there is no information about immunoregulatory microRNAs transported by exosomes and their correlation with clinical evolution during chemotherapy for acute myeloid leukemia. Knowledge about immunomodulatory microRNAs obtained by leukemic cells and transported by exosomes can direct us towards the design of new diagnostic and treatment tools in this type of leukemia.
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Leucemia Mieloide Aguda
/
MicroARNs
/
Exosomas
Tipo de estudio:
Estudio pronóstico
Límite:
Humanos
Idioma:
Inglés
Revista:
Einstein (Säo Paulo)
Asunto de la revista:
Medicina
Año:
2022
Tipo del documento:
Artículo
País de afiliación:
Brasil
Institución/País de afiliación:
Centro de Hematologia de São Paulo/BR
/
Faculdade Santa Marcelina/BR
Similares
MEDLINE
...
LILACS
LIS